Fig. 4From: LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapyPicture represents the combined effect of LSD1 inhibitor and ICB therapy on CD8 T cell action. “Figure created with BioRender.com” Back to article page